Invention Grant
- Patent Title: Use of DDX3 inhibitors as antiproliferative agents
-
Application No.: US16086791Application Date: 2017-03-23
-
Publication No.: US11000512B2Publication Date: 2021-05-11
- Inventor: Annalaura Brai , Maurizio Botta , Cristina Tintori , Giovanni Maga
- Applicant: AZIENDA OSPEDALIERA UNIVERSITARIA SENESE
- Applicant Address: IT Siena
- Assignee: AZIENDA OSPEDALIERA UNIVERSITARIA SENESE
- Current Assignee: AZIENDA OSPEDALIERA UNIVERSITARIA SENESE
- Current Assignee Address: IT Siena
- Agency: Lucas & Mercanti, LLP
- Priority: IT102016000031124 20160324
- International Application: PCT/EP2017/057010 WO 20170323
- International Announcement: WO2017/162834 WO 20170928
- Main IPC: A61K31/7056
- IPC: A61K31/7056 ; A61K31/4192 ; A61K31/18 ; A61K31/4196 ; A61K31/42 ; A61K31/4245 ; A61K31/433 ; A61K31/5377 ; A61K31/675 ; A61K31/41 ; A61K31/497 ; A61P35/04 ; A61K31/4439 ; A61K31/4725 ; A61K31/496 ; A61K45/06
Abstract:
The present invention refers to compounds of formula I or II endowed with DDX3 inhibitory activity, relative pharmaceutical compositions and their use as antihyperproliferative agents. (I) or (II).
Public/Granted literature
- US20190099403A1 USE OF DDX3 INHIBITORS AS ANTIPROLIFERATIVE AGENTS Public/Granted day:2019-04-04
Information query
